Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
Retina. 2019 Jun;39(6):1125-1132. doi: 10.1097/IAE.0000000000002106.
To evaluate the natural history of myelinated retinal nerve fiber layer (MRNFL) through clinical features and enhanced depth imaging optical coherence tomography.
This is a retrospective, noncomparative, case series of patients who underwent thorough clinical examination to document associated ocular and systemic features. Enhanced depth imaging optical coherence tomography was performed when MRNFL was located posteriorly and accessible to imaging.
Seventy-two eyes of 62 patients had a total of 86 MRNFL lesions. Enhanced depth imaging optical coherence tomography (n = 42 eyes) showed that all lesions originated in the nerve fiber layer with preservation of the vascular structures. Mean thickness by enhanced depth imaging optical coherence tomography was 255 μm (median, 182 μm; range, 61-717 μm). Natural history was obtainable in 58 lesions with a mean follow-up duration of 57 months (median, 37 months; range, 2-253 months) with no significant change overall in largest basal diameter (2.5 vs. 2.5 mm; P = 0.361) or thickness (255 vs. 240 μm; P = 0.053). However, evidence of lesion change included growth in base only (≥0.5 mm) (3 of 58; 5%), growth in base (≥0.5 mm) and thickness (≥50 μm) (3 of 58; 5%), and reduction in base (≥0.5 mm) after plaque radiotherapy for choroidal melanoma (3 of 58; 5%).
In general, MRNFL is a rare, benign retinal finding with a potential for growth in 10% of cases. This supports previous histopathological reports that MRNFL represents accumulation of both myelin and oligodendrocytes and could be an oligodendrocytic choristoma.
通过临床特征和增强深度成像光学相干断层扫描来评估有髓神经纤维层(MRNFL)的自然病史。
这是一项回顾性、非对照、病例系列研究,对患者进行了全面的临床检查,以记录相关的眼部和全身特征。当 MRNFL 位于后部且可进行成像时,进行增强深度成像光学相干断层扫描。
62 名患者的 72 只眼共有 86 处 MRNFL 病变。增强深度成像光学相干断层扫描(n=42 只眼)显示所有病变均起源于神经纤维层,血管结构保持完整。增强深度成像光学相干断层扫描的平均厚度为 255μm(中位数,182μm;范围,61-717μm)。在 58 处病变中获得了自然病史,平均随访时间为 57 个月(中位数,37 个月;范围,2-253 个月),最大基底直径(2.5 与 2.5mm;P=0.361)或厚度(255 与 240μm;P=0.053)总体上无显著变化。然而,病变变化的证据包括仅基底增大(≥0.5mm)(58 例中有 3 例;5%)、基底和厚度均增大(≥0.5mm 和≥50μm)(58 例中有 3 例;5%)以及脉络膜黑色素瘤斑块放疗后基底减小(≥0.5mm)(58 例中有 3 例;5%)。
一般来说,MRNFL 是一种罕见的良性视网膜病变,有 10%的病例有生长的可能。这支持了以前的组织病理学报告,即 MRNFL 代表髓鞘和少突胶质细胞的积累,可能是少突胶质细胞性脉络膜瘤。